Rigaku Analytical Devices to Host Roundtable Discussion in Partnership with American Pharmaceutical Review
Rigaku Analytical Devices will host an interactive roundtable discussion with real-world pharmaceutical industry professionals to discuss how handheld Raman technology has transformed workflows and maximized quality insight.
WILMINGTON, Mass., Sept. 2, 2020 /PRNewswire-PRWeb/ -- Rigaku Analytical Devices, the market leader in handheld 1064nm Raman technology, will moderate a roundtable discussion among industry professionals about successes and challenges of making changes to their organizations' pharmaceutical workflows. The roundtable will be hosted by American Pharmaceutical Review and will take place on October 15, 2020 at 10:00am PDT / 1:00pm EDT.
Panelists from a variety of leading pharmaceutical organizations will join moderator Jill Carreiro, Global Pharmaceutical Business Development Director at Rigaku Analytical Devices, at an interactive roundtable to discuss how handheld Raman technology has transformed workflows and maximized quality insight in their organizations. Panelists will review some of their own real-world challenges and successes in the implementation of Rigaku Progeny handheld 1064nm-Raman based instrumentation.
In the session titled, "Hear from Your Professional Peers: A Quality Perspective Roundtable Discussion on the Successes and Challenges of Making Changes to Pharma Workflow," attendees will learn:
- Challenges faced by pharmaceutical quality teams in their material analysis workflows, and real-world solutions
- How leading pharmaceutical manufacturers have adapted their quality processes to include handheld Raman
- What areas within their workflow leading manufacturers use handheld Raman
Anyone with a focus on quality control & assurance in pharmaceutical manufacturing, as well as Manufacturing Chemists, Validation Engineers, and Biopharmaceutical Scientists is encouraged to attend.
"We wanted to offer a different virtual experience for attendees during this time with an experience that is relatable to the challenges of the attendees," said Jill Carreiro. "We are absolutely thrilled to have representatives from global companies join this important panel discussion and for attendees to really "hear it straight from the horse's mouths."
To register for this event, please visit the American Pharmaceutical Review website. For more information on the Rigaku Progeny 1064nm handheld analyzer, please visit http://www.rigaku.com/Progeny.
About Rigaku Analytical Devices
Rigaku Analytical Devices is leading with innovation to pioneer a portfolio of handheld and portable spectroscopic analyzers for use in public health and safety, scientific and academic study, recycling and reuse of metal alloys, and to ensure the quality of key metal alloy components in critical industries. We strive to deliver quality, reliability and engaged expertise to our customers with our advanced product and capabilities and are dedicated to continual product development efforts to deliver mission critical enhancements to performance and functionality and reliable, cost-effective solutions for end users. Our rugged products operate on an open architecture platform and deliver unparalleled accuracy and support for rapid lab-quality results any time, any place.
For further information, contact:
Jen Lynch
Marketing Director
Rigaku Analytical Devices
Wilmington, MA USA
Tel: +1 781-328-1024
[email protected]
SOURCE Rigaku Analytical Devices
Share this article